The combined hepatitis A and B vaccine is usually administered as three separate doses over a 6-month period. A large randomized trial, conducted in 479 adults (aged 18 to 45 years) recruited from ...
Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today reported financial results for the fourth ...
Two top Louisiana officials who are physicians are encouraging residents to get vaccinated against measles as an outbreak ...
Assays for hepatitis B surface antigen (HBsAg) are the most frequently used tests to detect HBV infection. Vaccination for HBV can produce transiently detectable levels of HBsAg in patients.
A new study that has the potential to change the landscape of hepatitis B transmission in Africa. Researchers conducted an analysis revealing key interventions that could effectively eliminate ...
12d
Dynavax Technologies Corp (DVAX) reports record revenue for Heplisav-B, advances in vaccine programs, and strategic financial positioning despite rising R&D costs.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback